Orphanin FQ/nociceptin (OFQ/N) and its receptor share substantial structura
l features and cellular actions with classic opioid peptides and receptors,
but have distinct pharmacological profiles and behavioral effects. Current
ly there is an active debate about whether OFQ/N produces hyperalgesia or a
nalgesia. Using a well-defined brainstem pain-modulating circuit, we show t
hat OFQ/N can cause either an apparent hyperalgesia by antagonizing mu opio
id-induced analgesia or a net analgesic effect by reducing the hyperalgesia
during opioid abstinence. It presumably produces these two opposite action
s by inhibiting two distinct groups of neurons whose activation mediates th
e two effects of opioid administration. OFQ/N antagonism of the hyperalgesi
a may have significance for the treatment of opioid withdrawal and sensitiz
ed pain.